BreakingNews

Monthly archive

March 2017

U.S. Census Bureau Daily Feature for March 29: Mom and Pop Businesses

in BREAKING NEWS/Business and Finance/enterprise/local business/research market by
Reading Time: 1 minute

WASHINGTON, March 30, 2017 /360WiseNews/ — Following is the daily “Profile America” feature from the U.S. Census Bureau:

MOM AND POP BUSINESSES

Profile AmericaWednesday, March 29th. While shoppers and communities often welcome the opening of a major department store or a branch of a big-box chain, they are also the cause of some concern. Small local businesses face greater competition, yet those small businesses are an outsized engine of economic growth. Additionally, they are important distinguishing features in local communities. That’s why today is Mom and Pop Business Owners Day. In 2012, there were nearly 28 million business firms in the U.S., but only 5.4 million of them had paid employees. In that group, over 2.7 million– about half– were enterprises having four or fewer employees. Almost 10 million of America’s business enterprises are women-owned.  You can find current data on the country’s economy by downloading the ‘America’s Economy’ mobile application at www.census.gov/mobile.

Sources:
Occasion/accessed 1/5/2017:  http://www.cute-calendar.com/event/national-mom-and-pop-business-owners-day/13027-usa.html
Total business firms/Survey of Business Owners:  https://factfinder.census.gov/bkmk/table/1.0/en/SBO/2012/00CSA01/0100000US
Women-owned firms/Survey of Business Owners: https://factfinder.census.gov/bkmk/table/1.0/en/SBO/2012/00CSA01  Keep Reading

Indie Music Sensation Hello Kylie Releases New Single and Video

in BREAKING NEWS/campaign/children/Entertainment/Music/Press Release by
Reading Time: 2 minutes

11-year-old artist Hello Kylie drops new single called Feature From Quavo through the independent music label New Muzik Order.

LOS ANGELES, March 30, 2017 /360WiseNews/ — Hello Kylie is back with a new single that drops on all major streaming services, YouTube and in App Stores on March 29th. Hello Kylie is an 11-year-old artist from Los Angeles.  Her music has inspired a new generation to get out and play, make videos, and share with others online. Hello Kylie has been recording singles and making videos for years, while growing a following on musical.ly and Youtube that’s in the millions. Her latest single Feature from Quavo is being released by independent music label, New Muzik Order and is, according to them, her most mature and rounded single yet.

Kylie jumped on the music scene in 2016 when she released her 1st single “Sleep is for Suckas” (https://www.youtube.com/watch?v=MqkNvCp9VZk)  A video that featured a 10yr old Kylie visiting her grandmother in an “Old Folks” home which grew in the millions.

Kylie’s 2nd record Abracadabbra (https://www.youtube.com/watch?v=JjHB9S7vT4A) was released in Sept 2016 and had over 75 million musical.ly likes and views and over 500,000 videos were made using Hello Kylie’s song and hashtags.

Technology has brought about the rise of independent music labels and artists that might never have been seen without the help of social media platforms.  Hello Kylie’s YouTube channel has thousands of subscribers and millions of views. Working with New Muzik Order has helped the young songstress not only receive the production value in her music, but also has helped  artist  reach a wider audience. Keep Reading

Delta and Korean Air to Expand Partnership

in Airlines/BREAKING NEWS/international/Partnership/Press Release by
Reading Time: 3 minutes

Airlines agree to implement a joint venture arrangement that will grow trans-Pacific network, enhance customer benefits

ATLANTA and SEOUL, March 30, 2017 /360WiseNews/ — Delta Air Lines (NYSE: DAL) and Korean Air have reached an agreement to deepen their historic partnership, with an expanded trans-Pacific network that will increase travel choices and boost competition between the U.S. and Asia.

The airlines signed a memorandum of understanding to implement a joint venture arrangement, which will offer customers access to the most comprehensive route network, industry-leading airline products, world-class airport facilities and a seamless customer experience.

Highlights of the agreement, subject to regulatory approvals, include:

  • The intent to create a fully integrated trans-Pacific joint venture arrangement, with both airlines sharing the costs and revenues on flights and coordinating schedules for seamless, convenient connections.
  • A combined network, serving more than 290 destinations in the Americas and more than 80 in Asia, providing customers of both airlines with more travel choices than ever before.
  • Enhanced frequent flyer benefits, providing customers of both airlines the ability to earn and redeem miles on Delta’s Sky Miles and Korean Air’s SKYPASS programs.

“This agreement deepens our longstanding partnership with Korean Air and will provide the global access and seamless service our customers demand,” said Delta CEO Ed Bastian. “We look forward to providing customers of both carriers with industry-leading service between the U.S. and Asia.”

“This Joint Venture will benefit our customers by providing more convenient connection schedules and widen their opportunities in earning mileages,” said Korean Air’s Chairman and CEO, Yang Ho Cho. “With this agreement, we will reinforce Incheon airport’s position as a major international hub in North East Asia and support the growth of Korea’s aviation industry.”

Upon the signing of the final joint venture arrangement, Delta and Korean Air will work together to implement all aspects of the enhanced co-operation including expanded codesharing, frequent flyer programs and joint growth in the trans-Pacific market, with co-location at key hubs with seamless passenger and baggage transit experience. Keep Reading

OMRON to Introduce E5CD/E5ED Temperature Controllers Which Automatically Adjust Temperature like Skilled Workers Using AI for Production Sites, First Time in Industry (*)

in BREAKING NEWS/Business and Finance/Digital/Health/medical/Press Release/Technology/temperature by
Reading Time: 3 minutes

KYOTO, Japan, March 30, 2017 /360WiseNews/ — OMRON Corporation (TSE: 6645, ADR: OMRNY) will introduce on April 3, 2017, “E5CD/E5ED Temperature Controllers” to automatically adjust temperature parameters of heaters and others using AI that used to be done by skilled workers at production sites and “E52-CA xx AY S xx Temperature Sensors for Packaging Machines.”

OMRON will showcase the “E5CD/E5ED Temperature Controllers” and “E52-CA xx AY S xx Temperature Sensors for Packaging Machines” at the “2017 International Food Machinery & Technology Exhibition” to be held at Tokyo Big Sight from June 13 to 16.

(Photo1: E5CD/E5ED Temperature Controllers
http://prw.kyodonews.jp/prwfile/release/M102197/201703230211/_prw_PI1fl_2ZobErLL.png)

(Photo2: E52-CA xx AY S xx Temperature Sensors for Packaging Machines
http://prw.kyodonews.jp/prwfile/release/M102197/201703230211/_prw_PI2fl_JO25x72o.png)

The newly released E5CD/E5ED Temperature Controllers include OMRON’s unique temperature adjustment algorithm. The E5CD and E5ED automatically adjust temperature parameters that until now skilled workers have been doing based on experience and intuition in response to production status changes, including production items and materials compounding.

At today’s production sites, multi-product production makes manufacturing highly complicated. This accelerates production transfer to emerging countries for optimally located production, leading to product defects and lower productivity resulting from worker skill shortage. Especially in the molding and packaging processes, temperature adjustment required when production items change is not properly done. To avoid quality loss that is caused by temperature, the equipment operation speed slows down and inspection work takes more time at the expense of productivity. Keep Reading

National Electronic ID Program Revenue to Exceed $54 Billion Between 2016 and 2021 With 3.2 Billion Chip-Based National eID Cards in Circulation

in BREAKING NEWS/Business and Finance/Digital/global/Technology by
Reading Time: 3 minutes

DENVER, March 30, 2017 /360WiseNews/ — Leading digital identity analyst firm, Acuity Market Intelligence, forecasts that the global market for National Electronic ID (eID) programs will exceed $54 billion in revenues between 2016 to 2021. During the forecast period, Asia will account for more than 60% of all cards issued as the number of countries issuing National eID cards increases from 124 to 136.

Acuity’s report — “The Global National eID Industry Report: 2017 Edition” — projects that from 2016 to 2021, 3.2 billion chip-based National eIDs will be issued by 103 countries while 485 million National ID cards will be issued by 33 countries that integrate biometrics into non-chip based card programs.

According to Acuity Market Intelligence Principal, Maxine Most, “Just as adoption of chip-based ePassports created a global platform that has driven worldwide adoption of Automated Border Control eGates and Kiosks, growth of chip-based National eID programs is creating a foundation for national, regional, and ultimately global trusted authentication infrastructures that will drive expansion of eGovernment services and integration of commercial services like banking and payments.” Keep Reading

WuXi Biologics Receives Asia-Pacific Best Bioprocessing Excellence Award from IMAPAC

in award/BREAKING NEWS/global/medical/Technology by
Reading Time: 2 minutes

SHANGHAI, March 30, 2017 /360WiseNews/ — WuXi Biologics, a leading open-access R&D capability and technology platform company dedicated to biologics and a WuXi AppTec Affiliate, today announced that it had received the 2017 Asia-Pacific Best Bioprocessing Excellence Award from IMAPAC, a leading consulting firm.

Asia-Pacific Bioprocessing Excellence Awards aims to recognize outstanding leaders and trend-setters of today, and inspire innovators of tomorrow. Featuring top bioprocessing and biomanufacturing experts in the industry, along with the latest advances in technologies and best practices in manufacturing, WuXi Biologics has been recognized for its outstanding performance that facilitating biomanufacturing excellence at enhanced speed, reduced cost and superior quality.

As an open-access biologics technology platform, WuXi Biologics opened its state-of-the-art biologics manufacturing facilities at Wuxi city in 2012, which is the first in China that met cGMP standards of the United States, the European Union, and China. In 2015, WuXi began construction of world’s largest mammalian cell culture manufacturing facility using disposable bioreactors with a planned manufacturing capacity of 30000L, and completed construction of Asia’s largest perfusion biologics manufacturing facility using disposable bioreactors in 2016, offering end-to-end solution to our worldwide customers and partners. Keep Reading

South Atlantic Bancshares, Inc. Completes $20 Million Capital Raise

in banks/BREAKING NEWS/Business and Finance/finance by
Reading Time: 3 minutes

MYRTLE BEACH, S.C., March 30, 2017 /360WiseNews/ — South Atlantic Bancshares, Inc. (OTCQX: SABK) (the “Company”), parent of South Atlantic Bank, today announced the closing of a stock purchase with various investors from which it raised aggregate gross proceeds of $20 million through the issuance of its common stock. The securities offered were not registered under the Securities Act of 1933, as amended, or the securities laws of any state, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

In making the announcement, South Atlantic Bancshares Chairman and Chief Executive Officer, K. Wayne Wicker said, “The capital raise will support the bank’s continued growth and expansion. Since its opening in late 2007, the bank has grown to six offices, all located in some of the fastest-growing areas in the country. Additionally, improving economic conditions are fueling interest in expansion and new projects throughout our markets. Great opportunities for growth lie ahead for the markets we serve and our banking subsidiary. We are pleased to welcome our new shareholders and appreciate the confidence that they have in our Company.”

FIG Partners, LLC, an employee-owned broker/dealer based in Atlanta, Georgia, acted as the Company’s financial advisor in raising the new capital and Hunton & Williams LLP acted as legal counsel to the Company. Keep Reading

GHIT Fund Invests in Late-stage Trial for Child-friendly “Snail Fever” Medicines–One of the Most Debilitating and Widespread Parasitic Diseases in Africa

in BREAKING NEWS/children/Health/medicine by
Reading Time: 7 minutes

Completion of Phase 3 trial for treatment of “Snail Fever” (aka schistosomiasis) is final step before regulatory and WHO submission; GHIT also announces new investment in novel malaria vaccine and therapeutic for dengue, continued support for innovative tools to tackle malaria and neglected tropical diseases

TOKYO, March 30, 2017 /360WiseNews/ — The Global Health Innovative Technology Fund (GHIT Fund), a unique Japanese public-private partnership formed to battle infectious diseases around the globe, today announced 11 new investments totaling US$23 million* that could help deliver a range of new innovative therapies for a host of debilitating conditions.

This latest round of targeted support includes funding for a Phase 3 clinical trial testing a pediatric formulation of a drug considered the gold standard for treating schistosomiasis, a water-borne parasitic disease linked to an assortment of acute and chronic health problems. Young children are most at risk, but the existing drug is so bitter and hard to swallow that kids often go untreated, leading to serious lifelong health and learning problems.

This clinical trial is one of the most advanced partnerships invested by the GHIT Fund, an organization that combines Japan’s historic leadership in global health and innovation with groundbreaking research from across the globe. The GHIT Fund also is making new investments in two malaria vaccine candidates, while accelerating work to find new drug treatments for malaria, dengue, Chagas disease, cryptosporidiosis and leishmaniasis.

“We’re reaching an exciting phase where GHIT’s approach to partnerships and drug and vaccine development is starting to produce tangible progress towards product deployment that could eventually lead to revolutionary breakthroughs,” said BT Slingsby, MD, PhD, MPH, who is CEO of the GHIT Fund. “We knew that combining Japan’s wealth of biomedical research talent and pharmaceutical capabilities with leading infectious disease experts near and far was likely to be a winning combination, and that’s been validated by the progress we are seeing across a rich diversity of projects.”

A Snail Fever Drug That’s Easy to Swallow

Schistosomiasis, sometimes called “snail fever” because it’s found in freshwater snails, leads to both acute and chronic disease. It’s caused by parasitic worms known as blood flukes and is usually transmitted through contact with infested water. The disease is endemic in 78 developing countries and, according to the World Health Organization, more than 261 million people, including 100 million children, were infected with schistosomiasis in 2015. Some 90 percent of infections occur in Africa, where safe water is often scarce. While rarely fatal, left untreated, the disease can cause anemia, stunted growth, impaired learning ability and chronic inflammation of vital organs.

GHIT Fund’s investment of US$4.7 million, with co-funding from its partners, will support a Phase 3 clinical trial in Africa to evaluate a pediatric formulation of praziquantel (PZQ) in children aged three months to six years. Since the 1970s, the gold-standard of treatment for the disease has been a single oral dose of PZQ used to treat adults and school-aged children. But children under age five who are infected with schistosomiasis are not treated with PZQ under the current policy. And data on the treatment of these children has been sparse and insufficient to define and confirm the best dosing. In addition, the current tablets have a severe bitter taste and the large size of the existing pill makes it difficult or just impossible for small children to swallow. A smaller, more palatable pill that could be administered to children as young as three months old is being developed by the Pediatric Praziquantel Consortium, a nonprofit international public-private partnership involving Astellas Pharma Inc. (Japan), Lygature (The Netherlands), Merck KGaA (Germany), the Swiss Tropical and Public Health Institute, Simcyp Limited (UK), Farmanguinhos (Brazil) and the Schistosomiasis Control Initiative (SCI, UK). Keep Reading

Family Fights to Stop Hewlett Packard and Insurer From Cutting Off Healthcare that Saves Father’s Life, According to Federal Lawsuit by Jonathan Davidson Law Firm

in Health/Insurance/lawsuits by
Reading Time: 2 minutes

RIVERSIDE, Calif., March 30, 2017 /360WiseNews/ — According to a lawsuit filed in the federal District Court in the Northern District of California in San Jose, the experience of one patient, Jonathan Davidson, puts a spotlight on the large companies Hewlett Packard Enterprise and United HealthCare seeking to manipulate healthcare payment systems by cutting off a patient’s life-saving care, as alleged in the lawsuit in which Mr. Davidson’s Jonathan Davidson Law Firm is representing him. Hewlett Packard Enterprise (HP) plans a merger this week with another giant computer services company, Computer Sciences Corporation, which has repeatedly been charged with systematically engaging in false or fraudulent practices in its business with Medicaid, the British National Health Service and others. In the merger, 120,000 or so HP employees are set to be “spun off” into a newly created HP-CSC merger company called “DXC Technology,” with their prior HP sponsored health plan replaced by a “private exchange model” adopted for its “lower cost structure” for HP.

According to Jonathan Davidson, his case exemplifies the abuses that victimize millions of ill patients, including employees and others with company or group medical coverage, and also the public and taxpayers through inflated medical and health insurance costs. Keep Reading

Tens of Thousands of Orthodox Jews Protest Israel’s Military Draft Law

in advocacy/BREAKING NEWS/jews/Press Release/protest by
Reading Time: 2 minutes

JERUSALEM, March 30, 2017 /360WiseNews/ — Tens of thousands of Orthodox Jews gathered yesterday (Tuesday) to protest Israel’s Military Draft Law, resulting in the forced enlistment of many Orthodox Jews. The protestors also decried Israel’s brutal tactics to crack down peaceful protestors.

The demonstration was organized by the Edah HaChareidis – a Rabbinic umbrella association representing hundreds of Orthodox Jewish congregations with a combined membership of over 250,000. During the protest, leading Rabbis sharply attacked Israel’s conscription policy, passed in 2014, curtailing a 60 year old policy exempting all Yeshiva students from military service. Since then, many who refused to enlist were incarcerated for weeks and even months under brutal conditions. Those who peacefully protest those policies are subject to harsh punishments as well.

For instance, a father of seven, Rabbi Binyumin Friedman was recently incarcerated for peacefully protesting the draft. He was denied bail and is now scheduled to remain detained until the completion of his trial, which can take many months.

“The Israeli Army is an irreligious entity, and it is impossible for Orthodox Jews to fully practice their religion while in the army. We cannot serve in the army; because, the Torah prohibits us to create a state before the coming of Messiah… because, the Torah prohibits us to wage war against any sovereign nation!” declared Rabbi Issac Mark, the intergovernmental liaison for the Edah HaChareidis. Keep Reading

1 2 3 8
Go to Top